Allergy Therapeutics plc (AIM:AGY)

Allergy Therapeutics Statistics

Total Valuation

AIM:AGY has a market cap or net worth of GBP 675.56 million. The enterprise value is 722.86 million.

Market Cap	675.56M
Enterprise Value	722.86M

Important Dates

The last earnings date was Monday, December 29, 2025.

Earnings Date	Dec 29, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:AGY has 6.14 billion shares outstanding. The number of shares has increased by 27.33% in one year.

Current Share Class	6.14B
Shares Outstanding	6.14B
Shares Change (YoY)	+27.33%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	3.39%
Float	325.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.27
PB Ratio	-23.96
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.01
EV / Sales	13.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.04

Financial Position

The company has a current ratio of 1.28

Current Ratio	1.28
Quick Ratio	0.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.92
Interest Coverage	-4.47

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-26.58%
Return on Invested Capital (ROIC)	-50.69%
Return on Capital Employed (ROCE)	-70.59%
Revenue Per Employee	94,253
Profits Per Employee	-68,719
Employee Count	584
Asset Turnover	0.82
Inventory Turnover	1.93

Taxes

In the past 12 months, AIM:AGY has paid 932,000 in taxes.

Income Tax	932,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.77% in the last 52 weeks. The beta is 0.81, so AIM:AGY's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	+61.77%
50-Day Moving Average	9.61
200-Day Moving Average	8.07
Relative Strength Index (RSI)	57.92
Average Volume (20 Days)	312,333

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:AGY had revenue of GBP 55.04 million and -40.13 million in losses. Loss per share was -0.01.

Revenue	55.04M
Gross Profit	29.30M
Operating Income	-28.49M
Pretax Income	-39.20M
Net Income	-40.13M
EBITDA	-26.18M
EBIT	-28.49M
Loss Per Share	-0.01

Balance Sheet

The company has 12.79 million in cash and 60.09 million in debt, giving a net cash position of -47.30 million or -0.01 per share.

Cash & Cash Equivalents	12.79M
Total Debt	60.09M
Net Cash	-47.30M
Net Cash Per Share	-0.01
Equity (Book Value)	-28.19M
Book Value Per Share	-0.01
Working Capital	7.49M

Cash Flow

In the last 12 months, operating cash flow was -28.11 million and capital expenditures -3.26 million, giving a free cash flow of -31.37 million.

Operating Cash Flow	-28.11M
Capital Expenditures	-3.26M
Free Cash Flow	-31.37M
FCF Per Share	-0.01

Margins

Gross margin is 53.23%, with operating and profit margins of -51.75% and -72.91%.

Gross Margin	53.23%
Operating Margin	-51.75%
Pretax Margin	-71.22%
Profit Margin	-72.91%
EBITDA Margin	-47.56%
EBIT Margin	-51.75%
FCF Margin	n/a

Dividends & Yields

AIM:AGY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.33%
Shareholder Yield	-27.33%
Earnings Yield	-5.94%
FCF Yield	-4.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM:AGY has an Altman Z-Score of -3.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.55
Piotroski F-Score	2